Authors


Aliza Vigderman

Latest:

Increased Internet Usage and Cyberbullying

What can you do to prevent a child from being cyberbullied? Here are some tips from security expert, Aliza Vigderman at Security.org.


Darby J.E. Lowe, MSc

Latest:

Dual Diagnosis: Double the Stigma, Double the Trouble

Understanding the additive effects of stigma surrounding dual diagnosis with both substance use disorder and a mental illness.


Shervin Shadianloo, MD

Latest:

The Negative Impact of Current Legislation on Gender Diverse Adolescents

Due to discrimination's negative impact, transgender and gender-nonconforming youth are several times more likely than the rate of their cisgender peers to have depression and anxiety.


Sarah Fleming

Latest:

Science and Art in Cognitive Behavioral Therapy

"The root of the word 'create' or 'creativity' essentially means 'to grow.' That is probably what lies at the heart of what patients really want; they want to grow in terms of their relationships, their abilities, their passions and interests, their health, and in terms of whatever dreams they want to achieve personally in their lives."


Justin Allen, MD

Latest:

Exploring the Role of Brexpiprazole in Alzheimer Dementia Agitation

How efficacious is brexpiprazole as a treatment for agitation associated with Alzheimer disease?




David Scharff, MD, FABP

Latest:

Our Work and What the Award Means to Us: 2021 Sigourney Award Winners

These 2 Sigourney Award Winners share their journey to success.


Abigail Jaeger, MD

Latest:

Zuranolone for the Treatment of Adults With Major Depressive Disorder

This randomized, placebo-controlled, phase 3 clinical trial showed that a 14-day treatment course of oral zuranolone 50 mg/day in MDD led to significantly greater improvements in depressive symptoms when compared with placebo.



Seth Feuerstein, MD, JD

Latest:

The Expanding Role of Digital Therapeutics in Mental Health

What products have broken ground in the digital therapeutics space, and how can they help patients?


Adriane Bennett, PhD

Latest:

Benzodiazepine Use and the Risk of Dementia

Nearly half of the prescriptions for benzodiazepine among older adults are potentially inappropriate, so how best to do no harm?


Dwight E. Kemp, MD, MS

Latest:

Family. Food. Faith.

“We hold on to the promise because it continues to sustain us… and me.”


Tabark Altai, MD

Latest:

Social Anxiety Disorder: An Underappreciated Entity

Social anxiety disorder: an underappreciated and misunderstood condition.


Paul M. Grant, PhD

Latest:

Recovery-Oriented Cognitive Therapy: Changing Lives With a Whole-Person Approach

Are you ready to understand how recovery-oriented cognitive therapy (CT-R) promotes wellness and empowerment for individuals experiencing serious mental health challenges? Check out this CME article.


Charles Upchurch

Latest:

Physicians and Friends Find Healing and Purpose in The Ride for Mental Health

“The pervasive feeling shared by all is that regardless of your personal journey and experiences with mental health, you are not alone.”


Pallavi Joshi, DO, MA

Latest:

Can Semaglutide Help in Psychiatry Too? Research Shows Promise for AD and PD

Available evidence from preclinical studies indicates that semaglutide shows promise for treating Alzheimer disease and Parkinson disease.


Anne Williams-Wengerd, MA, LP

Latest:

Promoting Resiliency After First-Episode Psychosis

Simple but powerful strategies for drawing on patients’ existing character strengths and long-term goals.


Thomas Strouse, MD

Latest:

Let’s Ask the Right Questions About Medical Aid in Dying

Some patients are intractably and maybe even irredeemably ill. What should be done for them?


Cassandra L. Boness, PhD

Latest:

Nonabstinent Recovery From Alcohol Use Disorder

"Limiting definitions of recovery to abstinence and the absence of AUD symptoms fail to capture the multidimensional and heterogeneous pathways to recovery that research has shown to exist among both treatment-seeking and population samples."


Daniel Pick, PhD

Latest:

In Conversation With a Sigourney Award Winner: The Intersection of History, Humanities, and Psychoanalytic Thought

“Freudian thought has massively influenced not only modern understandings of mind and therapeutic treatment, but also modernism and many distinct visions of politics.”


Honor Hsin, MD, PhD

Latest:

Delivering Health Care Through Digital Mental Health Ecosystems

Here’s how a digital mental health ecosystem can seamlessly connect and support all facets of mental health care.


Timothy Mariano, MD, PhD, MSc

Latest:

Mental Health in America: A Growing Crisis

What are the greatest unmet mental health needs in the United States today? Recent statistics from the Centers for Disease Control may hold the answers.


Harold A. Maio

Latest:

The Power of Language

The sympathy, empathy, and pure common sense of considering the intent and effect of the terms we use.


Sara Parent, ND

Latest:

Contingency Management Is a Powerful Clinical Tool for Treating Substance Use Research Evidence and New Practice Guidelines for Use

Contingency management is an effective behavior change technique commonly used to treat substance use disorders.


Magali Haas, MD, PhD

Latest:

Avoiding a Brain Health Innovation Market Failure: Lessons from the Hype Cycle

New approaches to ensure that the brain health technology sector continues to flourish for decades.


Kyle Sramek, MD

Latest:

Phase 3 Trials Examine Gantenerumab for Early Alzheimer Disease

Two phase 3 trials were conducted to assess the clinical and biological effects as well as the safety of gantenerumab in individuals with mild cognitive impairment or mild dementia due to AD. Here's what you need to know.


Bryce Reynolds, MD

Latest:

Case-Based Psych Perspectives: Treating Schizophrenia in the Era of COVID-19

This article provides a summary of key points discussed in a Case-Based Psych Perspectives Series, shared by Bryce Reynolds, MD, and Hannah Phillips-Hall, MSN, PMHNP-BC.


Bethanie Simmons-Becil, DNP, MSN, APRN, PMHNP-BC, APHN-BC

Latest:

Unmet Needs in Bipolar Disorder Management

A psychiatric nurse practitioner shares gaps in care in bipolar 1 disorder treatment.


Daniel C. McFarland, DO

Latest:

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.

© 2024 MJH Life Sciences

All rights reserved.